Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
9.10
-0.34 (-3.60%)
Mar 6, 2026, 10:06 AM EST - Market open
Company Description
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.
The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes.
It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Embecta Corp.
| Country | United States |
| Founded | 1924 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 1,850 |
| CEO | Devdatt Kurdikar |
Contact Details
Address: 300 Kimball Drive, Suite 300 Parsippany, New Jersey 07054 United States | |
| Phone | 862 401 0000 |
| Website | embecta.com |
Stock Details
| Ticker Symbol | EMBC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001872789 |
| CUSIP Number | 29082K105 |
| ISIN Number | US29082K1051 |
| Employer ID | 87-1583942 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Devdatt Kurdikar Ph.D. | President, Chief Executive Officer and Chairman |
| Jacob P. Elguicze | Senior Vice President and Chief Financial Officer |
| Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development and Corporate Secretary |
| Jean M. Casner | Senior Vice President and Chief Human Resources Officer |
| Shaun Curtis | Senior Vice President of Global Manufacturing and Supply Chain |
| Anthony M. Roth | Vice President, Chief Accounting Officer and Corporate Controller |
| Pravesh Khandelwal | Vice President and Head of Investor Relations |
| Ginny Blocki | Senior Vice President of Strategy |
| Tom Blount | Senior Vice President and President of North America |
| Slobodan Radumilo | Senior Vice President and President of International |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 13, 2026 | 8-K | Current Report |
| Feb 5, 2026 | 10-Q | Quarterly Report |
| Feb 5, 2026 | 8-K | Current Report |
| Jan 30, 2026 | SCHEDULE 13G/A | Filing |
| Jan 23, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 18, 2025 | ARS | Filing |
| Dec 18, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 18, 2025 | DEF 14A | Other definitive proxy statements |
| Nov 25, 2025 | 10-K | Annual Report |
| Nov 25, 2025 | 8-K | Current Report |